Electrostimulation System WoundEL for Leg Ulcers Healing (
NCT04980898 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2025-08-06
Summary
Several studies have suggested that the endogenous electric field and its polarity stimulate the proliferation and migration of epithelial cells and therefore promote wound healing. WoundEL® will reproduce the endogenous electrical current to stimulate all the factors contributing to healing.
Electrostimulation of wounds, including the WoundEL® device, is a therapy listed but not yet reimbursed in France. The aim of this study is to show that the WoundEL® electrostimulation device is superior to the reference treatments recognized by the HAS.
Conditions
- Leg Ulcer
- Electrical Remodeling
Interventions
- DEVICE
-
WoundEL medical device
The WoundEl system is composed by: a class IIa device , a class IIb dressing electrode and a class I disperser electrode. Applied to the leg ulcer, WoundEL® reproduces the endogenous electrical current to stimulate all the factors contributing to healing. Electrical current is evenly spread over the Dressing Electrode which also maintains a moist wound healing environment.
- OTHER
-
Standard cares
Cleaning and monitoring
Sponsors & Collaborators
-
WoundEL Health Care
collaborator UNKNOWN -
CEN Biotech
lead INDUSTRY
Principal Investigators
-
HERVE MAILLARD, MD · Centre Hospitalier du Mans
-
LAURE-CECILE MARTIN · WoundEL Health Care
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-16
- Primary Completion
- 2023-11-17
- Completion
- 2023-11-17
Countries
- France
Study Locations
More Related Trials
-
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
NCT01853384 ·Status: TERMINATED ·Phase: PHASE3
-
Microlyte Dressing in the Management of Wounds
NCT03204851 ·Status: UNKNOWN ·Phase: NA
-
Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries
NCT03283787 ·Status: COMPLETED ·Phase: NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
NCT06707103 ·Status: RECRUITING ·Phase: PHASE3
-
AQUACEL® Ag Dressing and Urgotul® Silver Dressing on Healing of Chronic Venous Leg Ulcers
NCT01084577 ·Status: COMPLETED ·Phase: PHASE4
-
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
NCT02973893 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial Examining Cellular Energetics Related to Various Wound Treatment Therapies
NCT00605189 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Cold Plasma in Chronic Wound Healing
NCT06964048 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers
NCT02583958 ·Status: UNKNOWN ·Phase: NA
-
Effect of Prontosan Wound Irrigation Solution on Venous Ulcers
NCT01048307 ·Status: COMPLETED ·Phase: NA
-
Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers
NCT01427491 ·Status: COMPLETED ·Phase: PHASE3
-
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
NCT01396304 ·Status: TERMINATED ·Phase: PHASE4
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
NCT05588583 ·Status: RECRUITING ·Phase: NA
-
Clinical and Mechanistic Demonstration of a Bioelectric Dressing System for Non-healing Wound Management: A Phase II Trial
NCT01784887 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
NCT02248077 ·Status: WITHDRAWN ·Phase: PHASE4
-
VLU Non-Inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-Layer Bandaging
NCT02680834 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Woulgan in Diabetic Foot Ulcer
NCT02631512 ·Status: COMPLETED ·Phase: PHASE4
-
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
NCT01737762 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)
NCT04927702 ·Status: TERMINATED ·Phase: NA
-
AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®
NCT07308678 ·Status: COMPLETED
-
AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period
NCT05892341 ·Status: COMPLETED ·Phase: NA
-
DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers
NCT03044132 ·Status: COMPLETED ·Phase: NA
-
DermaRep™ Device in the Treatment of Venous Leg Ulcers
NCT03699072 ·Status: COMPLETED ·Phase: NA
-
ULCERS - Electrical Stimulation in Diabetic Foot Ulceration
NCT02211495 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Clinical Performance of Biatain Fiber Ag on Venous Leg Ulcers
NCT05873257 ·Status: COMPLETED ·Phase: NA